Inpatient CDS systems are being designed to integrate with electronic medical records (EMRs) and thus reduce scenarios of severe hypoglycaemia and recurrent hyperglycaemia, while minimising inappropriate use of insulin therapy that might lead to harm [50]. The gene discussed is INS; the disease is Hypoglycemia.